BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 34576042)

  • 1. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
    Chou MY; Yang MH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
    Chockley PJ; Keshamouni VG
    J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
    Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
    Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.
    Romeo E; Caserta CA; Rumio C; Marcucci F
    Cells; 2019 May; 8(5):. PubMed ID: 31096701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
    Dominguez C; David JM; Palena C
    Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multifaceted role of mesenchymal stem cells in cancer.
    Timaner M; Tsai KK; Shaked Y
    Semin Cancer Biol; 2020 Feb; 60():225-237. PubMed ID: 31212021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis.
    Baj J; Brzozowska K; Forma A; Maani A; Sitarz E; Portincasa P
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
    Jiang Y; Zhan H
    Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis.
    Romano S; Tufano M; D'Arrigo P; Vigorito V; Russo S; Romano MF
    Semin Cancer Biol; 2020 Feb; 60():181-190. PubMed ID: 31422157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.
    Frediani JN; Fabbri M
    Mol Cancer; 2016 May; 15(1):42. PubMed ID: 27231010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
    Chockley PJ; Chen J; Chen G; Beer DG; Standiford TJ; Keshamouni VG
    J Clin Invest; 2018 Apr; 128(4):1384-1396. PubMed ID: 29324443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the role of EMT in tumor immune escape.
    Terry S; Savagner P; Ortiz-Cuaran S; Mahjoubi L; Saintigny P; Thiery JP; Chouaib S
    Mol Oncol; 2017 Jul; 11(7):824-846. PubMed ID: 28614624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.